12:00 AM
 | 
Apr 13, 2009
 |  BioCentury  |  Strategy

BMS-Otsuka cancer deal

BMS-Otsuka cancer deal

Collaboration fee based on Sprycel and Ixempra net sales
Period Tier Otsuka...

Read the full 102 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >